Hematology

Latest Videos Indications Trial Updates Recent Conferences Expert Opinion

The Hematology Channel on VJRegenMed brings you the latest research and opinion in advanced therapies for hematological malignancies. Delve into the latest interview content from major international congresses.

Indications

ALL
AML
Myeloma
B-Cell Lymphoma
CLL
Non-Hodgkin Lymphoma
3:52
Outcomes of children and young adults with B-ALL following tisa-cel reinfusion
Kevin McNerney • 24 Feb 2023
8:25
CAR-T therapy in acute and chronic leukemias: current applications and future outlooks
John Gribben • 10 Feb 2023
2:21
Exploring the potential role of CD7-targeting CAR-T cells in T-ALL
Maksim Mamonkin • 10 Feb 2023
2:20
Overcoming barriers in treating liquid tumors with T-cell therapies
Michela Consonni • 1 Apr 2022
View All Videos
5:15
CD33 CRISPR/Cas9 gene-edited donor allograft in patients with AML at risk of relapse post-HSCT
John DiPersio • 21 Feb 2023
3:48
Preliminary results from Phase I study of CD123 CAR-T therapy in pediatric R/R AML
Swati Naik • 20 Feb 2023
8:25
CAR-T therapy in acute and chronic leukemias: current applications and future outlooks
John Gribben • 10 Feb 2023
2:15
Challenges with CAR-T therapy in AML & insights into IF-BETTER-gated CAR-T cells
Sascha Haubner • 10 Feb 2023
View All Videos
2:47
KarMMa-3 results: ide-cel vs standard regimens in triple-class exposed multiple myeloma
Sergio Giralt • 17 Feb 2023
1:05
Novel CAR-T constructs emerging for patients with multiple myeloma who experience loss of BCMA
Hermann Einsele • 10 Feb 2023
2:17
The importance of managing hematologic toxicity associated with CAR-T therapy
Marion Subklewe • 10 Feb 2023
2:45
Phase I study of CC-98633 in R/R multiple myeloma
Luciano Costa • 11 Dec 2022
View All Videos
6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu • 3 Jun 2021
3:07
Horizon scanning in anti-CD19 CAR T-cell therapy
Marco Alessandrini • 20 May 2021
3:05
Targetting cancer with allogeneic NK cell therapies
James Trager • 10 Mar 2021
2:09
CAR-NKs for B cell malignancies
James Trager • 10 Mar 2021
View All Videos
3:19
Safety and efficacy of LV20.19 CAR-T therapy in Richter’s transformation and R/R MCL
Nirav Shah • 15 Feb 2023
8:25
CAR-T therapy in acute and chronic leukemias: current applications and future outlooks
John Gribben • 10 Feb 2023
3:58
Results from the first-in-human trial of huCART19-IL18 in patients with R/R NHL and CLL
Jakub Svoboda • 11 Dec 2022
3:30
Second CD19-targeted CAR T-cell infusion for R/R B-cell malignancies
Jordan Gauthier • 28 Jan 2021
View All Videos
3:19
Safety and efficacy of LV20.19 CAR-T therapy in Richter’s transformation and R/R MCL
Nirav Shah • 15 Feb 2023
5:36
Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy
Veit Buecklein • 9 Dec 2022
1:23
CARBON trial: investigating CTX110 allogeneic CRISPR-Cas9–engineered CAR-Ts in R/R LBCL
Constantine Tam • 12 Dec 2022
3:58
Results from the first-in-human trial of huCART19-IL18 in patients with R/R NHL and CLL
Jakub Svoboda • 11 Dec 2022
View All Videos

Recent Conferences

ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies Congress 2021
ISCT 2021
ASGCT 2021
3:47
RP-L301 lentiviral gene therapy for PKD
Jose-Luis López-Lorenzo • 15 Nov 2021
7:24
An update on the Phase I trial evaluating RP-L301 in PKD
Jose-Luis López-Lorenzo • 15 Nov 2021
3:50
Gene therapy for PKD: addressing the unmet clinical need
Jose-Luis López-Lorenzo • 15 Nov 2021
3:42
GNT0003: AAV gene therapy for Crigler-Najjar syndrome
Lorenzo D'Antiga • 18 Nov 2021
View All Videos
2:20
Remaining barriers in commercializing advanced therapies
Pascal Touchon • 22 Oct 2021
3:59
ATA3219, ATA3271 & ATA188: T-Cell immunotherapy products in development
Pascal Touchon • 22 Oct 2021
3:58
Remaining challenges in developing cell therapies for cancer
Pascal Touchon • 22 Oct 2021
3:09
The current landscape of allogeneic CAR T-cell therapies
Pascal Touchon • 22 Oct 2021
View All Videos
1:24
Multiplex gene silencing for the development of allogeneic cell therapies
Sven Kili • 5 Oct 2021
View All Videos
4:33
ISCT 2021 highlights: therapeutic deception, global regulation & CAR-T
Aaron Levine • 28 May 2021
11:41
Advances in CAR T-cell expansion technology
Lei Yu • 3 Jun 2021
6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu • 3 Jun 2021
2:11
Addressing CAR-T manufacturing challenges
Bruce Levine • 28 May 2021
View All Videos
4:08
HSC gene editing: current approaches and remaining challenges
Valentina Vavassori • 27 May 2021
3:09
Vector-based therapies for metabolic disorders
Gloria Gonzalez-Aseguinolaza • 18 May 2021
4:17
miCAR: combining microRNA gene silencing with CAR expression
Marco Alessandrini • 20 May 2021
2:38
DARIC33 CAR T-cells in AML
Jacob Appelbaum • 12 May 2021
View All Videos
The content of VJRegenMed is intended for healthcare professionals